<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Gene therapy may be a promising approach for treatment of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>, although the efficiency of postischemic gene therapy is not established </plain></SENT>
<SENT sid="1" pm="."><plain>Our goal in this study was to examine the effects of gene transfer of interleukin-10 (IL-10), an antiinflammatory cytokine, after induction of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">Brain ischemia</z:e> was produced by either photochemical occlusion of distal middle cerebral artery for focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> or bilateral carotid occlusion for global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in spontaneously hypertensive rats </plain></SENT>
<SENT sid="3" pm="."><plain>Adenoviral vectors encoding human IL-10 (AdIL10) or beta-galactosidase (control) were injected into the lateral ventricle 90 or 60 minutes after focal or global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Five days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, IL-10, IL-1beta, or tissue <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha in the cerebrospinal fluid, <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, infiltrations of leukocytes/macrophages in the <z:mpath ids='MPATH_124'>infarct</z:mpath> area, or hippocampal neuronal damages were determined </plain></SENT>
<SENT sid="5" pm="."><plain>The transduced IL-10 was released to the cerebrospinal fluid from the ventricular wall and increased to 7623+/-2965 pg/mL 5 days after AdIL10 transfection </plain></SENT>
<SENT sid="6" pm="."><plain>Cerebral blood flow during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was not different between treatments in either focal or global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">Brain infarction</z:e> of the AdIL10 group was significantly smaller and infiltrations of leukocytes and macrophages were fewer in the IL-10 treatment than control </plain></SENT>
<SENT sid="8" pm="."><plain>Hippocampal neurons after global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> were more preserved, and the terminal deoxynucleotidyl transferase-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi>-<z:chebi fb="1" ids="15956">biotin</z:chebi> in situ nick end labeling-positive cells were diminished by the IL-10 gene transfer with attenuated IL-1beta and augmented tissue <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Postischemic gene transfer of IL-10 into the lateral ventricle attenuated <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> and hippocampal damages, suggesting the promise for treatment of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
</text></document>